DROXIA 6336 DROXIA 6336 Pill - purple capsule-shape, 19mm
Generic Name: hydroxyurea
Pill with imprint DROXIA 6336 DROXIA 6336 is Purple, Capsule-shape and has been identified as Droxia 300 mg. It is supplied by Bristol-Myers Squibb.
Droxia is used in the treatment of anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DROXIA 6336 DROXIA 6336
Droxia
- Generic Name
- hydroxyurea
- Imprint
- DROXIA 6336 DROXIA 6336
- Strength
- 300 mg
- Color
- Purple
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-6336
- Inactive Ingredients
-
citric acid monohydrate,
gelatin,
magnesium stearate,
sodium phosphate,
titanium dioxide,
D&C Red No. 28,
D&C Red No. 33,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
More about Droxia (hydroxyurea)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimetabolites
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.